GB2514846A

GB2514846A - Electrochemical-based analytical test strip with a soluble electrochemically active coating opposite a bare electrode

Info

Publication number: GB2514846A
Application number: GB1310211.6A
Authority: GB
Inventors: Alexander Cooper; James Iain Rodgers; Gavin Macfie
Original assignee: LifeScan Scotland Ltd
Current assignee: LifeScan Scotland Ltd
Priority date: 2013-06-07
Filing date: 2013-06-07
Publication date: 2014-12-10
Anticipated expiration: 2033-06-07
Also published as: EP3004857A1; JP6448627B2; GB2514846B; CA2914280A1; RU2015156527A; KR20160015370A; BR112015030333A2; AU2014276754B2; HK1205251A1; JP2016520844A; ES2694326T3; CN105452855A; GB201310211D0; US20160187283A1; WO2014195480A1; AU2014276754A1; EP3004857B1; HK1222904A1; TW201506396A; RU2656268C2

Abstract

An electrochemical-based analytical test strip (EBATS) for the determination of an analyte in a bodily fluid sample includes an electrically insulating base layer 110, patterned electrically conductive layer on the base layer and including a plurality of electrodes 122-128, and an enzymatic reagent layer 140 disposed on a portion of the patterned conductor layer and defining bare electrode(s) 122, 124 and a plurality of enzymatic reagent covered electrodes 126-128. The strip also includes a patterned spacer layer 150, top layer 170 having an underside surface 176, and a soluble electrochemically-active coating 160 disposed on the underside surface. The spacer layer and top layer define a sample-receiving chamber 180 within the strip. The soluble coating 160 is disposed on the underside surface within at least a portion the sample-receiving chamber and in an opposing relationship to the bare electrodes.

Description

ELECTROCHEMICAL-BASED ANALYTICAL TEST STRIP

WITH A SOLUBLE ELECTROCHEMICALLY-ACTIVE COATING

OPPOSITE A BARE ELECTRODE

FIELD OF THE INVENTION

[0001] The present invention relates, in general, to medical devices and, in particular, to analytical test strips and related methods.

BACKGROUND OF THE INVENTION

[0002] The determination (e.g., detection andlor concentration measurement) of an analyte in, or a characteristic of, a fluid sample is of particular interest in the medical field. For example, it can be desirable to determine glucose, ketone bodies, cholesterol, I ipoproteins, triglycerides, acetaminophen, hematocrit and/or HbAlc concentrations in a sample of a bodily fluid such as urine, blood, plasma or interstitial fluid. Such determinations can be achieved using analytical test strips, based on, for example, visual, photometric or electrochemical techniques. Conventional electrochemical-based analytical test strips are described in, for example, U.S. Patent Nos. 5,708,247, and 6,284,125, each of which is hereby incorporated in full by reference.

SUMMARY OF THE INVENTION

[0003] In a first aspect of the present invention there is provided an electrochemical-based analytical test strip for the determination of an analyte in a bodily fluid sample, the electrochemical-based analytical test strip comprising: an electrically insulating base layer; a patterned electrically conductive layer disposed on the electrically insulating base layer and including a plurality of electrodes; an enzymatic reagent layer disposed on a portion of the patterned conductor layer to define at least one bare electrode and a plurality of enzymatic reagent covered electrodes from the plurality of electrodes; a patterned spacer layer; a top layer having an underside surface; and a soluble electrochemically-active coating on the underside surface of the top layer; wherein at least the patterned spacer layer and top layer define a sample-receiving chamber within the electrochemical-based analytical test strip; and wherein the soluble electrochemically-active coating is disposed on the underside surface of the top layer within at least a portion the sample-receiving chamber and in an opposing relationship to the bare electrodes.

[0004] The soluble electrochemically-active coating may include a redox agent.

[0005] The soluble electrochemically-active coating may include an enzymatic mediator.

[0006] The soluble electrochemically-active coating may include ferricyan ide.

[0007] The soluble electrochemically-active coating may be enzyme-free.

[0008] The at least one bare electrode may be one bare electrode.

[0009] The soluble electrochemically-active coating may be disposed opposite the at least one bare electrode and spaced apart from the plurality of enzymatic reagent covered electrodes.

[0010] The soluble electrochemically-active coating may be spaced apart from the plurality of enzymatic reagent covered electrodes by a distance in the range of 150 micrometers to 450 micrometers.

[0011] The at least one bare electrode may be configured to generate a current response upon the introduction of a bodily fluid sample into the sample-receiving chamber that is measurable by an associated test meter.

[0012] The bodily fluid sample may be a whole blood sample and the current response of the at least one bare electrode may be dependent on hematocrit of the whole blood sample.

[0013] An electrochemical response of the bare electrode may independent of analyte concentration of the bodily fluid sample [0014] The bodily fluid sample may be a whole blood sample.

[0015] At least the top layer and soluble electrochemically-active coating may be integrated as an engineered top tape.

[0016] The analyte may be glucose and the bodily fluid sample may be a whole blood sample.

[0017] The soluble electrochemically-active coating and at least one bare electrode of the patterned electrically conductor layer may be separated by a vertical distance of in the range of approximately 50 micrometers to approximately 150 micrometers in the sample-receiving chamber.

[0018] In a second aspect of the invention, there is provided a method for employing an analytical test strip, the method comprising: introducing a bodily fluid sample into a sample-receiving chamber of an electrochemical-based analytical test strip, the electrochemical-based analytical test strip including: a top layer with an underside surface; at least one bare electrode in the sample-receiving chamber; and a soluble electrochemically-active coating on the underside surface within at least a portion the sample-receiving chamber and in an opposing relationship to the at least one bare electrode, and wherein the introduction is such that the soluble electrochemically-active coating operably dissolves in the bodily fluid sample; detecting an electrochemical response of the at least one bare electrode of the electrochemical-based analytical test strip; and determining an analyte in the bodily fluid sample based in part on the detected electrochemical response of the at least one bare electrode.

[0019] The electrochemical-based analytical test strip may further include: an electrically insulating base layer; a patterned electrically conductive layer disposed on the electrically insulating base layer and including a plurality of electrodes; an enzymatic reagent layer disposed on at least a portion of the patterned electrically conductor layer to define the at least one bare electrode and a plurality of enzymatic reagent covered electrodes from the plurality of electrodes and a patterned spacer layer; and wherein at least the patterned spacer layer and top layer define the sample-receiving chamber within the electrochemical-based analytical test strip; and [0020] The detecting of an electrochemical response may also include detecting an electrochemical response of the plurality of enzymatic reagent covered electrodes.

[0021] The soluble electrochemically-active coating may contain an enzymatic mediator.

[0022] The soluble electrochemically-active coating may contain a redox agent.

[0023] The soluble electrochemically-active coating may be enzyme-free.

[0024] The plurality of bare electrodes may be one bare electrode.

[0025] The soluble electrochemically-active coating may be spaced apart from the plurality of enzymatic reagent covered electrodes.

[0026] The electrochernical response of at least one bare electrode may be a current response.

[0027] The bodily fluid sample may be a whole blood sample and the current response of the at least one bare electrode may be dependent on hematocrit of the whole blood sample.

[0028] An electrochemical response of the at least one bare electrode may be independent of analyte concentration of the bodily fluid sample.

[0029] The bodily fluid sample may be a whole blood sample.

[0030] The analyte may be glucose and the bodily fluid sample may be a whole blood sample.

[0031] The soluble electrochemically-active coating and the at least one bare electrodes of the patterned electrically conductor layer may be separated by a vertical distance in the range of approximately 50 micrometers to approximately micrometers in the sample-receiving chamber.

BRIEF DESCRIPTION OF THE DRAWINGS

[0032] The accompanying drawings, which are incorporated herein and constitute part of this specification, illustrate presently preferred embodiments of the invention, and, together with the general description given above and the detailed description given below, serve to explain features of the invention, in which: FIG. 1 is a simplified exploded perspective view of an electrochemical-based analytical test strip according to an embodiment of the present invention; FIG. 2 is a simplified perspective view of the electrochemical-based analytical test strip of FIG. 1; FIG. 3 is a simplified cross-sectional side view of a portion of the electrochemical-based analytical test strip of FIG. 1 taken along line A-A of FIG. 2; FIG. 4 is a graphical depiction of electrochemical response current transients from a bare electrode of an electrochemical-based analytical test strip according to the present invention; FIG. 5 is a graphical depiction of glucose determination measurement bias for a conventional electrochemical-based analytical test strip and an electrochemical-based analytical test strip according to the present invention; and FIG. 6 is a flow diagram depicting stages in a method for determining an analyte in a bodily fluid sample according to an embodiment of the present invention.

DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

[0033] The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered.

The drawings, which are not necessarily to scale, depict exemplary embodimentsforthe purposeof explanation onlyand are not intended to limitthe scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.

[0034] As used herein, the terms "about" or "approximately" for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein.

[0035] In general, electrochemical-based analytical test strips for the determination of an analyte (such as glucose) in a bodily fluid sample (for example, a whole blood sample) according to embodiments of the present invention includes an electrically insulating base layer, a patterned electrically conductive layer disposed on the electrically insulating base layer that includes a plurality of electrodes, and an enzymatic reagent layer disposed on a portion of the patterned conductor layer and defining at least one bare electrode and a plurality of enzymatic reagent covered electrodes from the plurality of electrodes.

Electrochemical-based analytical test strips according to the present invention also include a patterned spacer layer, a top layer having an underside surface, and a soluble electrochemically-active coating (for example, a soluble redox agent containing coating or a soluble mediator-containing coating such as a ferrocyanide-containing coating) disposed on the underside surface of the top layer. In addition, at least the patterned spacer layer and top layer define a sample-receiving chamber within the electrochemical-based analytical test strip.

Moreover, the soluble electrochemically-active coating is disposed on the underside surface of the top layer within at least a portion the sample-receiving chamber and in an opposing relationship to the bare electrodes.

[0036] The determination of an analyte in a bodily fluid sample, such as the determination of glucose in a whole blood sample, using electrochemical-based analytical test strips can be susceptible to determination inaccuracies arising from variation in characteristics of the whole blood sample. For example, the hematocrit of whole blood samples is known to affect the accuracy of glucose determination in whole blood samples.

[0037] Electrochemical-based analytical test strips according to embodiments of the present invention are beneficial in that, for example, the soluble electrochemically-active coating results in an electrochemical response (such as a current response) at the bare electrode that can be used to compensate (i.e., correct) electrochemical responses from the enzymatic reagent covered electrodes for hematocrit affects or other bodily fluid samples that affect the diffusion rate of the soluble electrochemically-active component of the coating such as temperature and viscosity. It is hypothesized, without being bound, that an electrochemically-active component (such as a redox agent or mediator) from the soluble electrochemically-active coating diffuses through a bodily fluid sample at a rate that is dependent on hematocrit and that, therefore, the timing and/or magnitude of the electrochemical response at the bare electrode is an indirect measurement of the hematocrit and, therefore, can be employed to beneficially improve the accuracy of analyte determination.

[0038] Electrochemical-based analytical test strips according to the present invention are also beneficial in that they only require a single bare electrode, thus enabling a sample-receiving chamber that is advantageously low in volume.

However, if desired to provide redundancy or to improve accuracy, a plurality of bare electrodes can be employed in embodiments of the present invention. In addition, the electrochemical response of the bare electrode can be, for example, a current transient that is simply and inexpensively measured using typical test meter current measurement circuitry.

[0039] FIG. 1 is a simplified exploded perspective view of an electrochemical-based analytical test strip 100 according to an embodiment of the present invention. FIG. 2 is a simplified perspective view of electrochemical-based analytical test strip 100. FIG. 3 is a simplified cross-sectional side view of a portion of electrochemical-based analytical test strip 100 taken along line A-A of FIG. 2.

[0040] Referring to FIGs. 1-3, electrochemical-based analytical test strip 100 for the determination of an analyte (such as glucose) in a bodily fluid sample (for example, a whole blood sample) includes an electrically-insulating base layer 110, a patterned electrically conductive layer 120, an optional patterned insulation layer 130, enzymatic reagent layers 140a and 140b, a patterned spacer layer 150, a soluble electrochemically-active coating 160, atop layer 170 consisting of a patterned hydrophilic sub-layer 172 and a top tape 174.

Patterned hydrophilic sub-layer 172 of top layer 170 has an underside surface 176 (see FIG. 3 in particular).

[0041] Patterned electrically conductive layer 120 is disposed on electrically-insulating base layer 110 and includes a plurality of electrodes (i.e., bare electrodes 122 and 124 and enzymatic reagent covered electrodes 126, 127 and 128 as described further herein). Enzymatic reagent layers 140a and 140b are disposed on a portion of the patterned electrically conductor layer 120 to define bare electrodes 122 and 124 and enzymatic reagent covered electrodes 126, 127 and 128 (see FIG. 3 in particular wherein enzymatic reagent layers 140a and 14b are depicted as a single layer for simplicity). Soluble electrochemically-active coating 160 is disposed on underside surface 176 of top layer 170 within at least a portion of a sample-receiving chamber 180 and in an opposing relationship to bare electrodes 122 and 124 (see FIG. 3 in particular).

[0042] In the embodiment of FIGs. 1-3, at least the patterned spacer layer and top layer define a sample-receiving chamber 180 within electrochemical-based analytical test strip 100 (see FIG. 3 in particular where the introduction of a bodily fluid sample (i.e., blood) into sample-receiving chamber 180 is depicted with an arrow).

[0043] Electrically-insulating base layer 110 can be any suitable electrically-insulating base layer known to one skilled in the art including, for example, a nylon base layer, a polycarbonate base layer, a polyimide base layer, a polyvinyl chloride base layer, a polyethylene base layer, a polypropylene base layer, a glycolated polyester (FETG) base layer, or a polyester base layer. The electrically-insulating base layer can have any suitable dimensions including, for example, a width dimension of about 5 mm, a length dimension of about 27 mm and a thickness dimension of about 0.5 mm.

[0044] Electrically-insulating base layer 110 provides structure to electrochemical-based analytical test strip 100 for ease of handling and also serves as a base for the application (e.g., printing or deposition) of subsequent layers (e.g., a patterned electrically conductor layer).

[0045] Enzymatic reagent covered electrodes 126, 127, and 128 can be, for example, configured such that enzymatic reagent electrode 126 serves as a counter/reference electrode, enzymatic reagent covered electrode 127 serves as a first working electrode and enzymatic reagent covered electrode 128 serves as a second working electrode, respectively. Although, for the purpose of explanation only, electrochemical-based analytical test strip 100 is depicted as including a total of three enzymatic reagent covered electrodes, embodiments of electrochemical-based analytical test strips, including embodiments of the present invention, can include any suitable number of such electrodes.

[0046] Bare electrodes 122 and 124 and enzymatic reagent covered electrodes 126, 127 and 128 of electrochemical-based analytical test strip 100 can be formed of any suitable conductive material including, for example, gold, palladium, platinum, indium, titanium-palladium alloys and electrically conducting carbon-based materials including carbon inks. It should be noted that patterned electrically conductive layers employed in analytical test strips according to embodiments of the present invention can take any suitable shape and be formed of any suitable materials including, for example, metal materials and conductive carbon materials. -10-

[0047] Referring in particular to FIGs. 1 and 3, the configuration and disposition of enzymatic reagent covered electrodes 126, 127 and 128 and enzymatic reagent layers 140a and 140b are such that electrochemical-based analytical test strip 100 is configured for the electrochemical determination of an analyte (such as glucose) in a bodily fluid sample (such as, for example, a whole blood sample with a physiological hematocrit content) that has filled sample-receiving chamber 180.

[0048] Enzymatic reagent layer 140 is disposed on only a portion of patterned electrically conductive layer 120 such that bare electrodes 122 and 124 are defined (see FIG. 3). Only a single (i.e., one) bare electrode is required in electrochemical-based analytical test strips according to embodiments of the present invention. However, the embodiment of FIGs. 1-3 includes two bare electrodes for redundancy.

[0049] Enzymatic reagent layers 140a and 140b can include any suitable enzymatic reagents, with the selection of enzymatic reagents being dependent on the analyte to be determined. For example, if glucose is to be determined in a blood sample, enzymatic reagent layers 140a and 140b can include a glucose oxidase or glucose dehydrogenase along with other components necessary for functional operation. Enzymatic reagent layer 140a and 140b can include, for example, glucose oxidase, tn-sodium citrate, citric acid, polyvinyl alcohol, hydroxyl ethyl cellulose, potassium ferricyan ide, potassium ferrocyan ide, antifoam, fumed silica (either with or without a hydrophobic surface modification), PVPVA, and water. Further details regarding reagent layers, and electrochemical-based analytical test strips in general, are in U.S. Patent Nos. 6,241,862 and 6,733,655, the contents of which are hereby fully incorporated by reference. It should be noted that the amount of acidic material employed in enzymatic reagents (such as the citric acid and tn-sodium citrate mentioned above) is not sufficient to reduce the pH of a bodily fluid sample to the levels required to provide beneficially reduced interferent effects.

[0050] Patterned spacer layer 150 can be formed, for example, from a screen-printable pressure sensitive adhesive commercially available from Apollo Adhesives, Tamworth, Staffordshire, UK. In the embodiment of FIGs. 1 through 3, patterned spacer layer 150 defines outer walls of the sample-receiving chamber 180. Patterned spacer layer 150 can have a thickness of, for example, approximately 75 microns, be electrically nonconductive, and be formed of a polyester material with top and bottom side acrylic-based pressure sensitive adhesive.

[0051] Soluble electrochemically-active coating 160 is disposed on the underside surface 176 of patterned hydrophilic sub-layer 172 of top layer 170 within at least a portion of sample-receiving chamber 180 such that soluble electrochemically-active coating 160 is disposed above bare electrodes 122 and 124. Moreover, soluble electrochemically-active coating 160 is operably dissolvable in the bodily fluid sample such that, during use of electrochemical-based analytical test strip 100, an electrochemically-active component (such as a redox agent or mediator) of the soluble electrochemically-active coating will diffuse from the vicinity of underside surface 176 to bare electrodes 122 and 124 giving rise to an electrochemical response at bare electrodes 122 and 124. Since the diffusion rate of the electrochemically-active component is dependent on, for example, hematocrit of the bodily fluid sample, the timing and magnitude of the electrochemical response will depend on the hematocrit of the bodily fluid sample. The electrochemical response can be used in a suitable algorithm, to determine hematocrit and/or to compensate for the effect of hematocrit on glucose determination based on an electrochemical response of enzymatic reagent covered electrodes 126, 127 and 128.

[0052] It should be noted that in the embodiment of FIGs. 1-3, the soluble electrochemically-active coating is disposed in an opposing relationship to (i.e., opposite) bare electrodes 122 and 124, but is not in an opposing relationship to -12-enzymatic reagent covered electrodes 126, 127 and 128. Therefore, soluble electrochemically-active coating 160 does not significantly affect the electrochemical response of enzymatic reagent covered electrodes 126, 127 and 128. In addition, the soluble electrochemically-active coating is enzyme free, therefore eliminating any analyte concentration dependent enzymatic reagent effect on the electrochemical response of the bare electrode(s).

[0053] Soluble electrochemically-active coating 160 can contain any suitable electrochemically-active component that can undergo a redox reaction at the working potential of the bare electrode(s) including, for example, the reduced or oxidized forms of enzymatic mediators such as Potassium Ferricyanide, water soluble ferrocenes, water soluble ferrocinium salts, osmium complexes, quinones (such as hydroquinone, benzoquinone, phenanthrocquinones and derivatives thereof) phenathiozine derivatives, and Meldola's blue. Moroever, the electrochemically-active component can be a redox agent capable of undergoing at least electrode oxidation or electrode reduction. Such redox agents include, for example, iodide, iodine, thiosulfate salts, soluble oxidisable metal salts such as nitrates, chlorides, sulfates and phosphates of silver and copper along with other transition metals, complexes of manganese (e.g. potassium permanganate) or chromium (e.g. potassium dichromate), hypochlorite salts, amrnonium and organic amine salts, and unsaturated organic compounds such as maleic anhydride. Soluble electrochemically-active coating is typically enzyme-free to avoid creating an analyte-dependent response at the bare electrodes.

[0054] Soluble electrochemically-active coating 160 and the at least one bare electrodes of the patterned electrically conductor layer are separated by a vertical distance in the range of, for example, approximately 50 microns to approximately 150 microns in the sample-receiving chamber. If desired to avoid compensating for background response, the soluble electrochemically-active coating can be spaced apart from the plurality of enzymatic reagent covered -13 -electrodes by a distance in the range of, for example, 150 microns to 450 microns.

[0055] Top layer 170 can be, for example, a clear film with hydrophilic properties that promote wetting and filling of electrochemical-based analytical test strip 100 by a fluid sample (e.g., a whole blood sample). Such clear films are commercially available from, for example, 3M of Minneapolis, Minnesota U.S.A. and Coveme (San Lazzaro di Savena, Italy). Top layer 170 can be, for example, a polyester film coated with a surfactant that provides a hydrophilic contact angle < 10 degrees. Top layer 170 can also be a polypropylene film coated with a surfactant or other surface treatment. In such a circumstance, the surfactant coating serves as patterned hydrophilic sub-layer 172. Moreover, if desired, the soluble acidic material coating can be formulated as a hydrophilic coating and also serve as a patterned hydrophilic sub-layer. Top layer 170 can have a thickness, for example, of approximately 100pm.

[0056] Electrochemical-based analytical test strip 100 can be manufactured, for example, by the sequential aligned formation of patterned electrically conductive layer 120, patterned insulation layer 130, enzymatic reagent layers 140a and 140b, patterned spacer layer 150, mediator containing layer 160 and patterned hydrophilic sub-layer 172 onto electrically-insulating base layer 110. Any suitable techniques known to one skilled in the art can be used to accomplish such sequential aligned formation, including, for example, screen printing, photolithography, photogravure, chemical vapour deposition and tape lamination techniques.

[0057] FIG. 4 is a graphical depiction of electrochemical response current transients from a bare electrode of an electrochemical-based analytical test strip according to the present invention. FIG. 4 depicts electrochemical response current transients for whole blood sample of three different hematocrit concentrations. FIG. 5 is a graphical depiction of glucose determination -14-measurement bias for a conventional electrochemical-based analytical test strip and an electrochemical-based analytical test strip according to the present invention. In FIG. 5, the bias for the conventional electrochemical-based analytical test strip is labeled as "uncorrected" and the bias for the electrochemical-based analytical test strip according to the present invention is labeled "corrected." The label "corrected" refers to correction of the glucose determination based on the electrochemical response of the bare electrode following introduction of a whole blood sample into the sample-receiving chamber as described herein.

[0058] Prototype versions of electrochemical-based analytical test strip according to an embodiment of the present invention and as depicted in FIGs.

1-3 were created as follows. Ferrocyanide (obtained commercially from Sigma-Aldrich) was added to a 0.1M phosphate buffer (including dibasic and monobasic potassium phosphate obtained commercially from Sigma-Aldrich) to create a neutral pH 250mM ferrocyanide solution. Hydroxyethyl cellulose (HEC, commercially available from Ashlnd UK ltd., United Kingdom)), a thickening agent, was then added in the capacity of 0.1 g per 1 OmI of solution to increase the viscosity of the ferrocyanide solution. The ferrocyanide solution was then applied to a top layer (layer 170 in FIGs. 1-3) such that it would be in an opposing relationship to bare electrodes 122 and 124 only and allowed to dry. The ferrocyanide containing coating thus prepared was approximately 2 microns in thickness. The top layer with ferrocyanide-containing coating was then used to manufacture electrochemical-based analytical test strips according to the present invention using standard web-based manufacturing techniques.

[0059] Prototypes were employed to collect electrochemical responses from the bare electrodes and the enzymatic reagent covered electrodes following introduction of whole blood samples into the prototypes and the application of a 400 my bias to the prototypes. The whole blood samples had hematocrit levels -15 -of 20%, 42% and 60%, which is representative of physiological hematocrit levels.

FIG. 3 depicts the electrochemical response transients for the bare electrodes.

[0060] The data of FIG. 3 demonstrate a clear difference in electrochemical current response between the three Hct levels at a measurement time of 5 seconds with the lowest Hct sample producing the greatest current response and the highest Hct sample producing the smallest current response. This indicates that the diffusion of ferrocyanide from the ferrocyanide-containing coating (i.e., the soluble electrochemically-active coating) to the bare electrode's surface can be used as a measure of Hct. Furthermore, the glucose response (i.e., the electrochemical response of the enzymatic reagent covered electrodes, not shown in FIG. 3) was not impacted by the ferrocyanide containing coating.

[0061] The electrochernical response data from the bare electrodes and the enzymatic reagent covered electrodes glucose was used to calculate a corrected current value that was then used to remove the Hct effect from a glucose determination as follows. First, a correction factor was calculated using the following algorithm: Icorr = WE -C1(Ihc-C2) where: Icorr = corrected current used to calculate measured glucose; WE = summed current measured at the two enzymatic reagent covered working electrodes at five seconds (which is dependent on both Hct and glucose) Ii = current measured at a bare electrode at five seconds (which is Hct dependent but analyte (glucose) independent) C1 = 0.45, an experimentally determined coefficient; and C2 = 1.5, another experimentally determined coefficient. -16-

[0062] Coefficients C1 and C2 were determined in the electrochemical response region of greatest hematocrit sensitivity. In practice and if desired, the algorithm could also include thresholds based on WE such that when WE is below a predetermined critical value a correction would not be applied. Where WE is above a predetermined threshold value, a less aggressive correction using alternative values of C and C2 could be applied.

[0063] The determined (measured) glucose concentration was then calculated from the corrected current using the slope and intercept of an WE versus glucose concentration relationship obtained by testing glucose spiked blood at a nominal Hct as follows: Measured glucose = (Icoyr-glucose intercept)I(glucose slope) [0064] The corrected glucose value was then compared to a glucose measurement determined by a laboratory YSI instrument and bias between the two values calculated. This bias is plotted in FIG. 4 for both electrochemical-based analytical test strips according to the present invention and conventional electrochemical-based analytical test strips. The data of FIG. 4 indicates that use of electrochemical-based analytical test strips according to the present invention and the above described algorithms provides a beneficially flat slope of bias versus Hct (i.e., impact of Hct has been compensated) while conventional electrochemical-based analytical test strips in the absence of any correct algorithm exhibit a significant slope.

[0065] FIG. 6 is a flow diagram depicting stages in a method 200 for determining an analyte (such as glucose) in a bodily fluid sample (for example, a whole blood sample containing a physiological level of hematocrit) according to an embodiment of the present invention. Method 200 includes, at step 210, introducing a bodily fluid sample into a sample-receiving chamber of an electrochemical-based analytical test strip, the electrochemical-based analytical test strip including a top layer with an underside surface, at least one bare -17-electrode in the sample-receiving chamber, and a soluble electrochemically-active coating on the underside surface. At least a portion of the soluble electrochemically-active coating is within the sample-receiving chamber and disposed in an opposing relationship to (I.e., opposite to) the at least one bare electrode. Moreover, the introduction of the bodily fluid sample is such that the soluble electrochemically-active coating operably dissolves in the bodily fluid sample.

[0066] At step 220 of method 200, an electrochemical response (such as a transient current response) of the at least one bare electrode of the electrochemical-based analytical test strip is detected using an associated test meter. An analyte in the bodily fluid sample is then determined based in part on the detected electrochemical response of the at least one bare electrode (see step 230 of FIG. 6).

[0067] Once apprised of the present disclosure, one skilled in the art will recognize that method 200 can be readily modified to incorporate any of the techniques, benefits, features and characteristics of electrochemical-based analytical test strips according to embodiments of the present invention and described herein.

[0068] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that devices and methods within the scope of these claims and their equivalents be covered thereby. -18-

Claims

CLAIMS1. An electrochemical-based analytical test strip for the determination of an analyte in a bodily fluid sample, the electrochemical-based analytical test strip comprising: an electrically insulating base layer; a patterned electrically conductive layer disposed on the electrically insulating base layer and including a plurality of electrodes; an enzymatic reagent layer disposed on a portion of the patterned conductor layer to define at least one bare electrode and a plurality of enzymatic reagent covered electrodes from the plurality of electrodes; a patterned spacer layer; a top layer having an underside surface; and a soluble electrochemically-active coating on the underside surface of the top layer; wherein at least the patterned spacer layer and top layer define a sample-receiving chamber within the electrochemical-based analytical test strip; and wherein the soluble electrochemically-active coating is disposed on the underside surface of the top layer within at least a portion the sample-receiving chamber and in an opposing relationship to the bare electrodes.
2. The electrochemical-based analytical test strip of claim 1 wherein the soluble electrochemically-active coating includes a redox agent.
3. The electrochernical-based analytical test strip of claim 1 or claim 2 wherein the soluble electrochemically-active coating includes an enzymatic mediator. -19-
4. The electrochemical-based analytical test strip of any one of claims 1 to 3 wherein the soluble electrochemically-active coating includes ferricyanide.
5. The electrochemical-based analytical test strip of any one of claims 1 to 4 wherein the soluble electrochemically-active coating is enzyme-free.
6. The electrochemical-based analytical test strip of any one of claims 1 to 5 wherein the at least one bare electrode is one bare electrode.
7. The electrochemical-based analytical test strip of any one of claims 1 to 6 wherein the soluble electrochemically-active coating is disposed opposite the at least one bare electrode and spaced apart from the plurality of enzymatic reagent covered electrodes.
8. The electrochemical-based analytical test strip of claim 7 wherein the soluble electrochemically-active coating is spaced apart from the plurality of enzymatic reagent covered electrodes by a distance in the range of 150 micrometers to 450 micrometers.
9. The electrochemical-based analytical test strip of any one of claims 1 to 8 wherein the at least one bare electrode is configured to generate a current response upon the introduction of a bodily fluid sample into the sample-receiving chamber that is measurable by an associated test meter.
10. The electrochemical-based analytical test strip of claim9 wherein the bodily fluid sample is a whole blood sample and the current response of the at least one bare electrode is dependent on hematocrit of the whole blood sample.
11. The electrochemical-based analytical test strip of any one of claims 1 to wherein an electrochemical response of the bare electrode is independent of analyte concentration of the bodily fluid sample -20 -
12. The electrochemical-based analytical test strip of any one of claims 1 to 11 wherein the bodily fluid sample is a whole blood sample.
13. The electrochemical-based analytical test strip of any one of claims 1 to 12 wherein at least the top layer and soluble electrochemically-active coating are integrated as an engineered top tape.
14. The electrochemical-based analytical test strip of any one of claims ito 13 wherein the analyte is glucose and the bodily fluid sample is a whole blood sample.
15. The electrochemical-based analytical test strip of any one of claims 1 to 14 wherein the soluble electrochemically-active coating and at least one bare electrode of the patterned electrically conductor layer are separated by a vertical distance ot in the range of approximately 50 micrometers to approximately l5omicrometers in the sample-receiving chamber.
16. A method for employing an analytical test strip, the method comprising: introducing a bodily fluid sample into a sample-receiving chamber of an electrochemical-based analytical test strip, the electrochemical-based analytical test strip including: a top layer with an underside surface; at least one bare electrode in the sample-receiving chamber; and a soluble electrochemically-active coating on the underside surface within at least a portion the sample-receiving chamber and in an opposing relationship to the at least one bare electrode, and wherein the introduction is such that the soluble electrochemically-active coating operably dissolves in the bodily fluid sample; detecting an electrochemical response of the at least one bare electrode -21 -of the electrochemical-based analytical test strip; and determining an analyte in the bodily fluid sample based in part on the detected electrochemical response of the at least one bare electrode.
17. The method of claim 16 wherein the electrochemical-based analytical test strip further includes: an electrically insulating base layer; a patterned electrically conductive layer disposed on the electrically insulating base layer and including a plurality of electrodes; an enzymatic reagent layer disposed on at least a portion of the patterned electrically conductor layer to define the at least one bare electrode and a plurality of enzymatic reagent covered electrodes from the plurality of electrodes and a patterned spacer layer; and wherein at least the patterned spacer layer and top layer define the sample-receiving chamber within the electrochemical-based analytical test strip; and
18. The method of claim 16 or 17 wherein the detecting of an electrochemical response also includes detecting an electrochemical response of the plurality of enzymatic reagent covered electrodes.
19. The method of any one of claims 16 to 18 wherein the soluble electrochemically-active coating contains an enzymatic mediator.
20. The method of any one of claims 16 to 19 wherein the soluble electrochemically-active coating contains a redox agent.
21. The method of any one of claims 16 to 20 wherein the soluble electrochemical ly-active coating is enzyme-free.-22 -
22. The method of any one of claims 16 to 21 wherein the plurality of bare electrodes is one bare electrode.
23. The method of any one of claims 16 to 22 wherein the soluble electrochemically-active coating is spaced apart from the plurality of enzymatic reagent covered electrodes.
24. The method of any one of claims 16 to 23 wherein the electrochemical response of at least one bare electrode is a current response.
25. The method of any one of claims 16 to 24 wherein the bodily fluid sample is a whole blood sample and the current response of the at least one bare electrode is dependent on hematocrit of the whole blood sample.
26. The method of any one of claims 16 to 24 wherein an electrochemical response of the at least one bare electrode is independent of analyte concentration of the bodily fluid sample.
27. The method of any one of claims 16 to 26 wherein the bodily fluid sample is a whole blood sample.
28. The method of any one of claims 16 to 27 wherein the analyte is glucose and the bodily fluid sample is a whole blood sample.
29. The method of any one of claims 16 to 28 wherein the soluble electrochemically-active coating and the at least one bare electrodes of the patterned electrically conductor layer are separated by a vertical distance in the range of approximately 50 micrometers to approximately 150 micrometers in the sample-receiving chamber.-23 -